To identify potential CAR-Targets for chordoma, we evaluated 6 tumor antigens (PD-L1, B7-H3, B7-H4, VISTA, HER2 and HER3) by IHC in a cohort of 45 skull base chordoma clinical samples (Figure 1A). Here, ERBB2 is linked to chordoma.